Medical Technology

@xconomy.com 3 years ago

Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin

@xconomy.com 4 years ago

AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening

@xconomy.com 4 years ago

With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14

@xconomy.com 4 years ago

Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow

@techcrunch.com 4 years ago

UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company

@xconomy.com 4 years ago

MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms

@xconomy.com 5 years ago

Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise

@xconomy.com 5 years ago

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

@xconomy.com 5 years ago

Corza Health Emerges Led by Former NuVasive, GreatCall Executives

@xconomy.com 5 years ago

Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More

@xconomy.com 5 years ago

Magnolia Medical Captures $20M to Reduce Blood Culture Contamination

@xconomy.com 5 years ago

RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures